https://mk-2048inhibitor.com/t....he-negative-influenc
Pancreatic cyst aspirates are evaluated in this study using PancreaSeq to determine its value. PancreaSeq testing became available at our facility effective June 1, 2022. Fifty cyst aspirates were subjected to testing between June 1, 2022, and December 31, 2022. Analysis revealed 26 (52%) as non-diagnostic, 4 (8%) as negative, 1 (2%) as atypical, 17 (34%) suggestive of a mucinous cystic neoplas
Beğen
Yorum Yap
Paylaş
